Mufemilast
Psoriasis (and potentially Atopic Dermatitis)
Phase 2/3Active
Key Facts
Indication
Psoriasis (and potentially Atopic Dermatitis)
Phase
Phase 2/3
Status
Active
Company
About Hemay Pharmaceutical
Chinese biotech developing novel small molecule drugs for dermatological and oncological conditions with a patient-centered, cost-effective approach.
View full company profile